Indication
Hematopoietic Stem Cells
2 clinical trials
2 products
Product
VedolizumabClinical trial
A Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy and Safety of Vedolizumab in the Prophylaxis of Intestinal Acute Graft Versus-Host Disease in Subjects Undergoing Allogeneic Hematopoietic Stem Cell TransplantationStatus: Completed, Estimated PCD: 2022-02-07
Clinical trial
A Prospective Cohort Study of Efficacy, Safety and Characterization of Immune Response to Vaccinations in Hematopoietic Stem Cell Transplant RecipientsStatus: Completed, Estimated PCD: 2021-01-21
Product
Immune Biomarkers